Inflectra

Could Pfizer's at-risk Inflectra launch set a biosimilars precedent for Amgen, Novartis?
Fierce Pharma
Mon, 10/24/16 - 09:50 am
Pfizer
drug launches
biosimilars
Inflectra
Amgen
Novartis
Pfizer set to start shipping Remicade biosimilar next month
Yahoo/Reuters
Tue, 10/18/16 - 12:03 am
Pfizer
Remicade
biosimilars
Inflectra
JNJ
rheumatoid arthritis
Pfizer Takes Aim at Johnson & Johnson
Motley Fool
Mon, 09/12/16 - 09:23 am
Pfizer
JNJ
Remicade
biosimilar
Inflectra
J&J Remicade Patent Found Invalid in U.S. Victory for Pfizer
Bloomberg
Thu, 08/18/16 - 04:13 pm
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Celltrion
Hospira
Will the approval of Inflectra be a biosimilar adoption tipping point?
BioPharma Dive
Fri, 06/10/16 - 10:18 am
Inflectra
biosimilars
Celltrion
Remicade
JNJ
rheumatoid arthritis
FDA Licenses a Second Biosimilar – The Parameters of Approval Come Into Better Focus
FDA Law Blog
Thu, 04/7/16 - 09:49 am
FDA
biosimilars
JNJ
Remicade
Inflectra
Pfizer
Celltrion
FDA approves 1st cheaper version of J&J's top drug Remicade
Yahoo/AP
Tue, 04/5/16 - 10:16 pm
FDA
Remicade
JNJ
Inflectra
biosimilars
Celltrion
Pfizer
If Pfizer's Right, Hospira Biosimilar Gold Rush Begins This Week
Forbes
Mon, 02/16/15 - 11:55 am
Pfizer
Hospira
M&A
biosimilars
Inflectra
Europe
autoimmune disease
Biogen's Biosimilars Vs. Amgen, Johnson & Johnson
Seeking Alpha
Mon, 12/23/13 - 10:01 am
Amgen
Biogen Idec
biosimilars
JNJ
Samsung Bioepis
Celltrion
Hospira
Remsima
Inflectra
Biosimilar versions of Remicade given EU green light
Reuters
Fri, 06/28/13 - 10:15 am
Remicade
biosimilars
Europe
Celltrion
Remsima
Hospira
Inflectra
rheumatoid arthritis

Pages